Laxmi Dental Ltd

AGM Details

• AGM held on 25 September 2026 at 10:00–11:04 IST via VC/OAVM.

Key Resolutions

• Ordinary resolution: Adoption of standalone financial statements for FY 2025-26.
• Ordinary resolution: Adoption of consolidated financial statements for FY 2025-26.
• Ordinary resolution: Re-appointment of the Whole-time Director, liable to retire by rotation.
• Special resolution: Variation in IPO proceeds utilization and extension of timeline.

Voting Results

• Resolution 1 passed by majority.
• Resolution 2 passed by majority.
• Resolution 3 passed with 99.964% in favour.
• Resolution 4 passed with 99.9984% in favour.

Dividend

• No dividend proposed or declared.

Director Changes

• Re-appointment of the Whole-time Director approved; retire by rotation.

Auditors

• No auditor appointments or changes disclosed.

Material Related Party Transactions

• No material related-party transactions disclosed.

Other Material Approvals

• Approval for variation in IPO proceeds utilization and extension of timeline.

AGM Details

• AGM held on Sep 25, 2026 at 10:00 a.m. via VC/OAVM.
• AGM concluded at 11:04 a.m. including e-voting.
• Remote e-voting held Sep 22–24, 2026; cut-off Sep 18, 2026.

Resolutions

• Ordinary: Adoption of standalone financial statements for year ended Mar 31, 2026.
• Ordinary: Adoption of consolidated financial statements for year ended Mar 31, 2026.
• Ordinary: Re-appointment of Rajesh Vrajlal Khakhar as director retiring by rotation.
• Special: Variation in IPO proceeds utilization and extension of the utilization timeline.

Voting results

• Voting results not disclosed in this filing; will be disseminated to exchanges.
• Voting results not disclosed; Scrutinizer’s report to be published.
• Voting results not disclosed; re-appointment remains subject to approval.
• Voting results not disclosed; special resolution awaiting announcement.

Director changes

• Re-appointment of Rajesh V. Khakhar as director retiring by rotation.

Laxmi Dental Limited trading window closed from October 01, 2026 till 48 hours after the declaration of un-audited (standalone and consolidated) financial results of the Company for the quarter and half year ended September 30, 2026

Meeting Details

• Date and time: 29 September 2026, 9:00 AM onwards.
• Nature: 1x1 / group Non-Deal Roadshow meeting.
• Organised by: Motilal Oswal Financial Services.
• Location: Mumbai (meeting venue not specified).
• Participants: Company officials will participate; no specific roles named.
• Purpose: Discussions based on publicly available information.
• Materials: Presentations will be posted on the company website.
• Recordings/transcripts: Available on the company website.

Meeting Details

• Date: 28 September 2026.
• Time: 9:00 AM onwards.
• Nature: Non-Deal Roadshow.
• Type: 1x1 / Group Meeting.
• Organised by: Motilal Oswal Financial Services.
• Location: Mumbai (physical).

Participants

• Company officials to participate (roles not disclosed).

Purpose

• Purpose: Non-Deal Roadshow for investor interaction.

Additional Notes

• Information will be available on the company's website.

ESOP listing approval

• NSE and BSE approved listing and trading of 7,911 ESOP shares.
• Trading admitted on September 18, 2026.
• Distinctive numbers 55021510 to 55029420.
• Face value Rs 2 per share.
• Under Laxmi Dental Employee Stock Option Scheme 2024.
• Approval letters dated 17 September 2026 enclosed.

Financial highlights

• Consolidated revenue: INR 2,864.04 million; PAT: INR 289.17 million.
• Consolidated EBITDA: INR 434.00 million; EBITDA margin 15.62%.
• Consolidated PAT margin: 10.41% for FY2025-26.
• YoY revenue growth: 16.21% in FY2025-26.
• Standalone revenue from operations: INR 2,085.56 million; Standalone PAT: INR 193.37 million.

Geography and product mix

• Geographic revenue: India INR 1,333.13 million; International INR 727.24 million; total INR 2,060.37 million.
• Laboratory domestic revenue: INR 883.63 million; international INR 784.06 million.
• Aligners revenue components: BDPL INR 393.84 million; Vedia Solutions INR 337.92 million.
• Digital lab penetration: domestic 75.53%; international 75.22%.

Operations and scale

• Six manufacturing facilities and five supporting facilities totaling ~1,47,000 sq ft.
• Intraoral scanners sold: 1,009 units in 2025-26.
• Six manufacturing facilities and international export reach to 95+ countries.
• Total workforce: 2,513 employees.

IPO proceeds and deployment

• IPO net proceeds: INR 1,281.70 million; 62.47% utilised by 18 Aug 2026.
• Unutilised IPO proceeds: INR 481.03 million; redeployment proposed.
• redeployment to land acquisition, building infra, and movable assets for 2027-28.

Dividend and capital returns

• Board did not declare any dividend for FY2025-26.
• Dividend distribution policy is available on the company's website.

Subsidiaries and joint ventures

• Material subsidiaries: Bizdent Devices Private Limited; Laxmi Dental Lab USA Inc.
• Joint ventures/associates: Kids-e-Dental LLP; IDBG AI Dent Global Private Limited; ECGPlus Technologies.
• BDPL merger with Laxmi Dental Limited approved; awaiting regulatory clearance.
• IDBG AI Dent Global Private Limited became a Joint Venture.

Governance and ESOPs

• Board had 8 meetings; Independent Directors held separate meeting on Feb 10, 2026.
• Anil Tilakraj Arora appointed as Additional Non-Executive Director w.e.f. Aug 29, 2025; regularised Sep 29, 2025.
• ESOP 2024: 59,360 equity shares allotted to eligible employees; 7,911 shares approved for vesting.
• ESOP outstanding at year-end: 3,06,884 options; 44,788 options forfeited.

CSR and sustainability

• CSR spend: INR 1.44 million (approx 1.44 million).
• 2% of average net profit allocated for CSR; PMNRF funded.
• CSR policy updated; annual CSR report attached.

Audit, controls and risk

• Internal financial controls assessed as adequate; no material weaknesses.
• Secretarial audits conducted; annual secretarial compliance report submitted.
• No frauds reported by auditors; governance framework aligned with SEBI LODR.

Regulatory and forward-looking

• Company pursuing variation in IPO object utilisation; requires 90% approval for special resolution.
• Plan to leverage unutilised IPO proceeds for land, building, and equipment; regulatory approvals pending.

AGM Details

• AGM on 25 September 2026 at 10:00 a.m. IST via VC/OAVM.
• Cut-off for voting eligibility: 18 September 2026.
• Meeting conducted via VC/OAVM; proxies not available.

Ordinary Business

• Adopt standalone financial statements for year ended 31 March 2026.
• Adopt consolidated financial statements for year ended 31 March 2026.
• Re-appoint Rajesh Vrajlal Khakhar as Whole-time Director, liable to rotate.

Special Business

• Approve variation in IPO proceeds utilisation and extension of timeline for new objects 6 and 7.
• Approval subject to at least 90% votes; otherwise variation not implemented.
• As of 18 August 2026, unutilised IPO proceeds amount to 481.03 million.
• Board approved the variation on 27 August 2026, subject to shareholder approval.

Director Details

• Re-appoint Rajesh Vrajlal Khakhar as Whole-time Director; tenure 2024-2029.
• Remuneration proposed at 93.00 lakh; last drawn 93.00 lakh.
• Shareholding in company: 93,17,526 equity shares.
• Board attendance: 100% in 2025-26; 75% in 2026-27 to date.

Other Approvals / Notes

• BDPL merger with the company pending Regional Director approval.
• LOI for land acquisition executed on 30 July 2026.